MedPath

A randomized controlled trial on the efficacy and safety of Gegen Qinlian decoction in the treatment of Damp-heat Type colorectal cancer

Phase 1
Recruiting
Conditions
Colorectal Cancer
Registration Number
ITMCTR2100004460
Lead Sponsor
Zhejiang Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. The patients who meet the diagnostic criteria of Colorectal cancer,staged as stage III or IV,and conformed to the standard of syndrome differentiation of damp-heat type in traditional Chinese medicine.
2. Age between 18 to 75 years.
3. Karnofsky performance status (KPS)>= 60,those patients who are expected to survive for more than 3 months from the day of enrollment.
4. No other traditional Chinese medicine, preparations affecting immune function, antibiotics or probiotics were used within 3 weeks.
5. Sign the patient's informed consent.

Exclusion Criteria

1. Complicated with serious heart, lung, liver, kidney and other diseases or other serious diseases, including uncontrolled active infection, severe electrolyte disturbance and obvious bleeding tendency, or serious complications (such as active gastrointestinal bleeding, gastrointestinal perforation, obstruction, jaundice);
2. The women who are pregnant or lactating.
3. A history of mental illness such as dementia or epilepsy.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival (OS);Progression-free survival (PFS);Contrast-enhanced CT/MRI of the abdomen;Objective Response Rate (ORR);
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath